Position in MLTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,806,539
-$1,167,059 QoQ
Shares Held
246,869
-23.0% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#44
of 172 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLTX Over Time
Shares Held
Position Value (USD)
Derivatives in MLTX
reported options exposure · as of Jun 30, 2026CallValue
$128,502
CallShares
6,600
PutValue
$52,569
PutShares
2,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. MLTX ranks #20 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in MLTX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,502 | 6,600 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $4,806,539 | 246,869 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $52,569 | 2,700 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $119,296 | 6,400 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $946,912 | 50,800 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $5,973,598 | 320,472 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $998,411 | 75,752 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $89,624 | 6,800 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $719,628 | 54,600 | Call | Sole | 2026-02-13 | |
| 2025-09-30 | $83,172 | 11,600 | Call | Sole | 2025-11-14 | |
| 2025-03-31 | $1,045,669 | 26,764 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,311,718 | 208,896 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $43,320 | 800 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $151,260 | 3,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $161,344 | 3,200 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $3,793,643 | 86,278 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,852,828 | 136,429 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $25,115 | 500 | Call | Sole | 2024-05-15 | |
| 2023-09-30 | $3,871,782 | 67,926 | Shares | Sole | 2023-11-21 | |
| No filing history on record for this holder in this stock. | ||||||